Specialty Medications in Personal Injury Cases
James Wong — Founder & Pharmacist, LienScripts | November 17, 2025 | 9 min read
Specialty medications are increasingly prescribed in personal injury cases for severe pain, nerve damage, and complex injuries. Learn what specialty drugs are, when they are appropriate, and how they affect pharmacy lien amounts.
Specialty Medications in Personal Injury Cases
Most personal injury medication regimens consist of standard oral medications — NSAIDs, muscle relaxants, nerve pain medications, and occasionally short-term opioids. But for patients with more severe or complex injuries, specialty medications may enter the picture. These medications carry higher costs, require more clinical oversight, and can significantly affect the economics of a case.
This guide explains what specialty medications are, when they are used in personal injury treatment, and what attorneys and patients should know about their role in lien-based care.
[!KEY] Specialty medications share common traits: high cost, complex administration, limited distribution, and monitoring requirements. They appear most in cases involving CRPS, traumatic brain injury, post-surgical recovery, and treatment-refractory neuropathic pain. A single specialty drug can double or triple a pharmacy lien. Insurance auditors scrutinize specialty lien amounts aggressively. Clinical pharmacist review is not optional — it is the documentation foundation that defends the lien at settlement.
What Makes a Medication "Specialty"?
There is no single universal definition, but specialty medications generally share several characteristics:
- High cost — Specialty drugs carry substantially higher price points than standard generics, due to complex manufacturing, limited competition, and distribution requirements.
- Complex administration — Many specialty medications are injected, infused, or require special handling rather than being simple oral tablets.
- Limited distribution — They may only be available through specialty pharmacies rather than standard retail pharmacies.
- Clinical monitoring requirements — Patients on specialty medications often need regular lab work, imaging, or other monitoring.
- Temperature sensitivity — Many biologics and injectable medications require cold chain storage and careful handling.
[!NOTE] The FDA maintains a searchable database of approved drug products through Drugs@FDA, which includes prescribing information and approval history for specialty medications commonly used in PI cases. For formulary and distribution classification references, the National Council for Prescription Drug Programs (NCPDP) establishes industry-standard definitions for specialty drug designation.
When Specialty Medications Are Used in PI Cases
Severe Inflammatory Conditions
Patients with significant soft tissue injuries, joint damage, or spinal inflammation that does not respond to standard anti-inflammatory medications may be prescribed injectable corticosteroids or other specialty anti-inflammatory agents. These are typically administered by a physician rather than dispensed at a pharmacy.
Nerve Damage and Neuropathic Pain
When standard nerve pain medications like gabapentin or pregabalin do not adequately control neuropathic pain, prescribers may turn to specialty options. These can include higher-cost formulations, extended-release preparations, or medications that require specialty pharmacy dispensing.
Chronic Pain Syndromes
Some accident victims develop chronic pain conditions like Complex Regional Pain Syndrome (CRPS) that require aggressive, multi-modal treatment. Specialty medications used in these cases may include:
- Ketamine infusions or compounded ketamine preparations
- Specialized nerve block medications
- Botulinum toxin injections for muscle spasticity and pain
- Advanced topical compounds with multiple active ingredients
Post-Surgical Recovery
Patients who require surgery after an accident — spinal fusion, joint reconstruction, hardware placement — may need specialty medications during their recovery. These can include injectable blood thinners to prevent clots, specialty wound care products, or advanced pain management medications.
Traumatic Brain Injury
Patients with traumatic brain injuries (TBI) may require specialty medications for seizure prevention, cognitive support, or management of post-concussive symptoms. Some of these medications are expensive, particularly newer anticonvulsants and neurological agents.
Specialty Medications and Pharmacy Liens
Specialty medications create unique considerations in the pharmacy lien context:
[!KEY] Specialty medications in a pharmacy lien are the line items most likely to be challenged at settlement — but a pharmacist-authored clinical narrative explaining why standard alternatives were tried and failed, and what the specialty drug achieved clinically, is typically sufficient to defend the charge against an adjuster's pharmacy benefit consultant review.
Cost Impact
A single specialty medication can double or triple the total pharmacy lien amount. For attorneys, this means the medication needs robust clinical justification to withstand scrutiny at settlement. Insurance auditors will pay special attention to high-cost specialty medications and may challenge their medical necessity aggressively.
Pricing Complexity
Specialty drug pricing involves complex variables beyond standard generic pricing. Robust documentation is especially important for specialty medications, where pricing is influenced by limited competition, distribution restrictions, and clinical complexity. Attorneys should request detailed pricing documentation for any specialty medication on a lien.
Specialty Pharmacy Access
Not every pharmacy in a lien network can dispense specialty medications. Patients needing specialty drugs may need to use a specialty pharmacy that has the appropriate licensing, storage capabilities, and clinical support staff. A lien program with access to specialty pharmacies ensures these patients are not left without options.
Prior Authorization Parallels
In the insurance world, specialty medications typically require prior authorization — a process where the insurance company reviews clinical documentation before approving the medication. While lien-based prescriptions do not go through insurance, the same principle of clinical review applies. A clinical pharmacist should review specialty prescriptions to confirm they are appropriate for the patient's condition and documented injuries.
Common Specialty Medications in PI Cases
While every case is different, certain specialty medications appear more frequently in personal injury treatment:
Injectable Corticosteroid Preparations
Methylprednisolone acetate (Depo-Medrol) and triamcinolone acetonide (Kenalog) are commonly used for joint and epidural injections. While the medications themselves are not extremely expensive, the procedures to administer them add significant cost.
Extended-Release Pain Formulations
Extended-release versions of medications like gabapentin (Gralise), pregabalin (Lyrica), or topiramate may be prescribed for their improved dosing convenience and steady-state blood levels. These are often significantly more expensive than their immediate-release counterparts.
Compounded Specialty Preparations
Compound medications — custom-prepared formulations mixing multiple active ingredients — occupy a gray area between standard and specialty medications. Compounded topical pain creams, for example, can contain combinations of ketamine, gabapentin, lidocaine, and anti-inflammatory agents. They are prepared by compounding pharmacies and priced based on the individual ingredients.
Muscle Spasticity Agents
For patients with spinal cord injuries or severe spasticity, medications like baclofen (including intrathecal baclofen pumps), dantrolene, or tizanidine at higher doses may be prescribed. These require careful clinical monitoring and dose titration.
What Attorneys Should Know
[!TIP] Before a case with specialty medications goes to demand, ask your lien partner for three things: (1) the clinical rationale for each specialty medication, (2) documentation that standard alternatives were considered or tried first, and (3) a pricing breakdown formatted for the demand package. Having these ready before the adjuster asks eliminates the most common challenge points.
Document the Medical Necessity
For every specialty medication on a pharmacy lien, ensure there is clear clinical documentation explaining why it was prescribed, what standard alternatives were tried first (if applicable), and what outcome the medication achieved. This documentation is your defense against audit challenges.
Understand the Pricing
Request a breakdown of how the specialty medication was priced. Compare the amount to publicly available pricing information. If the pricing seems disproportionate, have a conversation with your lien partner about the methodology.
[!KEY] The presence of a specialty medication — particularly for CRPS, TBI, or treatment-refractory neuropathic pain — in the pharmacy record signals a severe injury that has outlasted standard first-line treatment; for demand purposes, the specialty drug itself is evidence of injury complexity that supports a higher non-economic damages claim.
Monitor the Treatment Timeline
Specialty medications should have a clear start date, clinical rationale, and — for most — an expected end date or review date. Open-ended specialty prescriptions without documented clinical reassessment may draw scrutiny.
Prepare for Challenges
Insurance carriers are increasingly hiring pharmacy benefit consultants to review specialty medication claims. Prepare your response in advance by having clinical narratives, medical records, and pricing documentation organized and ready.
The Role of Clinical Pharmacist Review
A clinical pharmacist is essential when specialty medications are part of the treatment plan. The pharmacist can:
- Verify that the specialty medication is clinically appropriate for the injury
- Ensure proper dosing and monitoring are in place
- Document the medical necessity in a clinical narrative
- Identify potential interactions with the patient's other medications
- Provide expert opinion if the medication is challenged at settlement
Specialty medications are a growing part of the personal injury medication landscape. When they are clinically appropriate and properly documented, they represent necessary treatment that should be fully reimbursed. The key is clinical oversight, transparent pricing, and thorough documentation.
For more information about managing complex medication regimens in personal injury cases, visit our attorney resources page.
Related Resources
Frequently Asked Questions
What qualifies as a specialty medication in a PI case?
Specialty medications in personal injury cases are generally high-cost drugs that require special handling, monitoring, or limited-distribution dispensing. Common examples include injectable corticosteroid preparations, extended-release nerve pain formulations, compounded topical pain agents, and medications for Complex Regional Pain Syndrome or traumatic brain injury. Their presence on a pharmacy lien requires robust clinical documentation of medical necessity.
Are specialty medications covered under pharmacy liens?
Yes, specialty medications can be covered under pharmacy lien arrangements when clinically justified. The key requirements are clear documentation of why standard medications were insufficient, a clinical narrative supporting medical necessity, and transparent pricing documentation. Insurance auditors scrutinize specialty drug lien amounts closely, so thorough records are essential to defend these claims at settlement.
How do specialty drugs affect the total pharmacy lien amount?
A single specialty medication can significantly increase the total pharmacy lien, sometimes doubling or tripling it compared to a standard medication regimen. Attorneys handling cases with specialty prescriptions should anticipate that these line items will draw heightened attention during lien negotiation. Clinical narratives and medical records connecting each specialty drug to the accident-related injury are critical to defending the full lien amount.
Why do specialty medications require prior authorization from insurers?
Specialty medications require prior authorization because their high cost and clinical complexity demand insurer review before approval. In a pharmacy lien context, standard insurance prior authorization does not apply — but the same principle of clinical review is essential. A clinical pharmacist should verify that the specialty medication is appropriate for the documented injury and that standard alternatives were appropriately considered first.
What is a compounded medication in a personal injury case?
Compounded medications in personal injury cases are custom-prepared formulations — often topical pain creams — that combine multiple active ingredients like lidocaine, ketamine, or gabapentin into a single application. They occupy a gray area between standard and specialty medications. Compounded preparations on a pharmacy lien require clinical justification showing why a commercial product was insufficient for the patient's specific pain management needs.